Health
5.2
Merck Acquires Silence Therapeutics for ~€1B, Gains Rare Blood Cancer Drug
Published 6 h ago1 sourceEvidence: Reported
SeverityModerateLe SoirLow-rated sourceDE · GB
TechUnknownMedium
4.6
Isomorphic Labs faces delivery test in AI drug discovery push
Isomorphic Labs, Alphabet's AI drug discovery unit, is under scrutiny over whether its computational platform can produce viable medicines. The piece questions the firm's ability to translate AI breakthroughs into clinical candidates, a key uncertainty for the sector. This matters as AI-driven pharma bets hinge on tangible pipeline progress.
Score Breakdown
Mosaic Score4.6
Model confidence0.5
Significance0.5
Source credibility0.1
Related signals
8 foundPolitics
9.3
AI deepfakes flood US midterm ads; laws lag as $137M spent
Published 12 h ago7 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyAxiosUS
Markets
7.8
China Q3 GDP beats forecasts at 4.5% on AI-driven export boom
Published 12 h ago4 sourcesEvidence: Reported
SeverityHighGuardian WorldLow-rated sourceCN
Tech
7.4
Anthropic in talks for $45B data center deal with Nscale, boosting AI infrastructure
Published 50 min ago2 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyInfoMoneyUS
Tech
7.2
AI Infrastructure Boom Stalls: US Data Center Delays Mount, Investor Patience Wanes
Published 11 h ago3 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyRzeczpospolitaLow-rated sourceUS
Geopolitics
7.1
China shifts to regulate AI exports, reversing open approach
Published 2 d ago1 sourceEvidence: Reported
SeverityHighAssessedDeveloping storyLe MondeCN
Energy
7.1
US to Reopen Three Nuclear Plants to Power AI Data Centers
Published 2 h ago2 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyExpresoLow-rated sourceUS
Markets
7.0
Semiconductor stocks post longest losing streak since 2008 on AI doubts
Published 7 h ago1 sourceEvidence: Reported
SeverityHighAssessedDeveloping storyLa RepúblicaLow-rated sourceUS